Psygen Industries Ltd. is pleased to announce that its wholly-owned subsidiary, Psygen Labs Inc., received a dealer’s licence issued by Health Canada on January 17, 2022. Upon completion of its facility in Calgary, Psygen will begin onsite manufacturing of synthetic psychedelics in accordance with Good Manufacturing Practices (GMP) for use in clinical and scientific research.
Category Press Release
Published in Yahoo Finance